Age-related macular degeneration (AMD) is an eye disease that may get worse over time. It’s the leading cause of serious, permanent vision loss in people older than 50. About 1 in 10 people in the U.S. are affected by the condition. ...
According to the Age-Related Eye Disease Study (AREDS) [15], the macular region considered when discussing age-related macular degeneration (AMD) is a circular area with a radius of 2 times diameter of the optic disk (2 disc diameters (2 DD)) centered on the fovea. Meanwhile, it can be...
There is an active and controversial debate about the role of intravitreal bevacizumab versus approved drugs in the treatment of neovascular age-related macular degeneration (AMD). Because bevacizumab was available prior to the launch of ranibizumab, off-label use of the former became widespread and ...